GlassScriptPhysician profile
Jay T Segarra
NPI 1831244540
$8,589.98
in general payments reported to CMS, 2019-2025
40 companies · $1,485 in 2025
The $1,485 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,341 · 2020: $558 · 2021: $1,130 · 2022: $1,587 · 2023: $1,270 · 2024: $1,219 · 2025: $1,485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,778 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,777.64 |
| Education | $197.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,534.49 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $672.34 | 2019-2025 | Tezspire, Breztri |
| Mallinckrodt Hospital Products INC. | $645.90 | 2022-2025 | Acthar |
| Actelion Pharmaceuticals US, INC. | $613.87 | 2019-2023 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $419.30 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Grifols USA, LLC | $409.84 | 2019-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $260.21 | 2019-2024 | Yupelri |
| Electromed, INC. | $252.15 | 2019-2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $251.99 | 2020-2025 | Glassia |
| Regeneron Healthcare Solutions, INC. | $249.93 | 2019-2025 | Dupixent |
| Genentech USA, INC. | $244.33 | 2019-2022 | |
| Genzyme Corporation | $223.18 | 2019-2025 | |
| Insmed, INC. | $210.19 | 2019-2025 | Brinsupri, Arikayce |
| United Therapeutics Corporation | $170.28 | 2022-2025 | Tyvaso, Tyvaso |
| Ani Pharmaceuticals, INC. | $156.08 | 2023-2024 | Purified Cortrophin Gel |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $143.90 | 2023-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Baxter Healthcare | $123.53 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Bayer Healthcare Pharmaceuticals INC. | $118.49 | 2022-2023 | |
| Sunovion Pharmaceuticals INC. | $105.84 | 2019 | |
| Amgen INC. | $105.14 | 2021-2024 | Tezspire |
| Viatris Specialty LLC | $90.94 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $67.77 | 2019-2023 | Belsomra, Zerbaxa, Dificid |
| Vifor Pharma, INC. | $66.77 | 2024-2025 | Zemaira |
| Shire North American Group INC | $47.44 | 2019 | |
| Mallinckrodt Enterprises LLC | $41.56 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $41.21 | 2021 | |
| Verona Pharma, INC. | $40.25 | 2025 | Ohtuvayre |
| Circassia INC. | $37.32 | 2019 | |
| Jazz Pharmaceuticals INC. | $34.67 | 2021-2022 | |
| Ethicon INC. | $34.64 | 2022 | |
| Lilly USA, LLC | $24.52 | 2025 | Zepbound |
| Idorsia Pharmaceuticals US INC | $19.72 | 2023 | Quviviq |
| Liquidia Technologies, INC. | $19.28 | 2025 | Yutrepia |
| 3b Medical, INC. | $18.19 | 2025 | Luna |
| Novartis Pharmaceuticals Corporation | $17.37 | 2019 | |
| Itamar Medical INC | $17.10 | 2024 | Watchpatone |
| Inspire Medical Systems, INC. | $16.84 | 2025 | Inspire |
| Apria Healthcare LLC | $15.94 | 2021 | |
| Paratek Pharmaceuticals, INC. | $14.59 | 2021 | |
| Astellas Pharma US INC | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Segarra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.